Norel Ad Tablet, Multilayer
NDC Package 52747-475-70

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Norel Ad (acetaminophen, chlorpheniramine maleate, and phenylephrine hcl) tablets is do not take more than directed (see overdose warning)adults and children 12 years of age and over: take 1 tablet every 4 hours, while symptoms persistdo not take more than 6 tablets in 24 hours, unless directed by a doctorchildren under 12 years of age: ask a doctor. This formulation utilizes a tablet, multilayer delivery system. Marketed by U.s. Pharmaceutical Corporation, this product is identified by NDC 52747-475 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
52747-475-70
Package Description
20 TABLET, MULTILAYER in 1 BOTTLE
Product Code
52747-475
11-Digit Billing Format
52747047570
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
20 EA
RxNorm Crosswalk
  • RxCUI: 1193293 - acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Tablet
  • RxCUI: 1193293 - acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Tablet
  • RxCUI: 1193293 - APAP 325 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Norel Ad
Non-Proprietary Name
Acetaminophen, Chlorpheniramine Maleate, And Phenylephrine Hcl
Substance Name
Acetaminophen; Chlorpheniramine Maleate; Phenylephrine Hydrochloride
Dosage Form
Tablet, Multilayer - A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Do not take more than directed (see overdose warning)adults and children 12 years of age and over: take 1 tablet every 4 hours, while symptoms persistdo not take more than 6 tablets in 24 hours, unless directed by a doctorchildren under 12 years of age: ask a doctor

Regulatory & Marketing

Labeler Name
U.s. Pharmaceutical Corporation
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-27-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52747-475-70 identifies a specific commercial package of 20 tablet, multilayer in 1 bottle of Norel Ad, a human over the counter drug labeled by U.s. Pharmaceutical Corporation. This tablet, multilayer is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by U.s. Pharmaceutical Corporation on April 27, 2012. The current certification is valid through December 31, 2026.

How is this U.s. Pharmaceutical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52747047570. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 20 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52747-475-70
11-Digit CMS (5-4-2)
52747-0475-70

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.